Pain Medicine Specialist: Championing High-Quality Development for Neuromodulation Technology
Ming Chen , Yang-jia Shi , Kun Chen , Hong-bing Xiang
Current Medical Science ›› : 1 -11.
Neuromodulation technology, an interdisciplinary field integrating neuroscience, engineering, and clinical medicine, offers novel therapeutic paradigms for numerous intractable diseases. In pain medicine, it modulates nervous system function through electrical or chemical signals, emerging as a core approach for managing refractory pain. However, the rapid advancement of this technology has coincided with a persistent underappreciation of the core value and multidimensional roles of pain physicians. This paper systematically elucidates the essence and scope of neuromodulation technology, analyzes its unique advantages in addressing the diagnostic and therapeutic challenges of refractory pain, and reviews its rapid developmental trajectory. It critically highlights the indispensable, yet often underestimated, role of pain physicians in driving the high-quality advancement of this field. Furthermore, this paper explores safety concerns in clinical applications and highlights the need to establish robust monitoring, evaluation, and education systems. Finally, future directions for pain specialists in leading the evolution of neuromodulation are outlined.
Neuromodulation technology / Pain medicine / High-quality development / Pain physicians / Nervous system modulation / Refractory pain
| [1] |
|
| [2] |
|
| [3] |
|
| [4] |
|
| [5] |
|
| [6] |
|
| [7] |
|
| [8] |
|
| [9] |
|
| [10] |
|
| [11] |
|
| [12] |
|
| [13] |
|
| [14] |
|
| [15] |
Murphy C, Matikainen-Ankney B, Chang YH, et al. Optogenetically-inspired neuromodulation: Translating basic discoveries into therapeutic strategies. Emerging Horizons in Neuromodulation: New Frontiers in Brain and Spine Stimulation. Amsterdam: Elsevier; 2021:187–219. |
| [16] |
|
| [17] |
|
| [18] |
|
| [19] |
|
| [20] |
|
| [21] |
|
| [22] |
|
| [23] |
|
| [24] |
|
| [25] |
|
| [26] |
|
| [27] |
|
| [28] |
|
| [29] |
|
| [30] |
|
| [31] |
|
| [32] |
|
| [33] |
|
| [34] |
|
| [35] |
|
| [36] |
|
| [37] |
New Oxford-led project aims to revolutionise chronic pain treatment. Oxford: University of Oxford; 2025 Oct 17 [cited 2026 May 7]. Available from: https://www.ox.ac.uk/news/2025-10-17-new-oxford-led-project-aims-revolutionise-chronic-pain-treatment. |
| [38] |
|
| [39] |
|
| [40] |
North J, Calodney A, Trainor D, et al. Spinal cord stimulation plus conventional medical management versus conventional medical management alone for severe, non-surgical, refractory back pain: a randomized clinical trial followed by crossover. Reg Anesth Pain Med. 2025:rapm–2024–106335. |
| [41] |
|
| [42] |
|
| [43] |
|
| [44] |
|
| [45] |
|
| [46] |
Mangano N, Torpey A, Devitt C, et al. Closed-loop spinal cord stimulation in chronic pain management: mechanisms, clinical evidence, and emerging perspectives. Biomedicines. 2025;13(5). |
| [47] |
|
| [48] |
|
| [49] |
|
| [50] |
|
| [51] |
|
| [52] |
|
| [53] |
Pope JE, Smith GL, Goree JA, et al. Clinical utility of ECAP dosing in a real-world population delivered via EVOKE therapy: the ECAP study. Reg Anesth Pain Med. 2025:rapm–2025–107051. |
| [54] |
|
| [55] |
|
| [56] |
|
| [57] |
|
| [58] |
|
| [59] |
|
| [60] |
|
| [61] |
|
| [62] |
|
| [63] |
|
| [64] |
|
| [65] |
|
| [66] |
|
| [67] |
|
| [68] |
|
| [69] |
|
| [70] |
|
| [71] |
|
| [72] |
|
| [73] |
|
| [74] |
|
| [75] |
|
| [76] |
|
| [77] |
|
| [78] |
|
| [79] |
|
| [80] |
|
| [81] |
|
| [82] |
|
| [83] |
Al-Faraj K, Hanel PHP, Valentini E. Brain responses during provoked pain in patients with chronic primary pain: a systematic review and meta-analysis of fMRI studies. J Pain. 2026:106218. |
| [84] |
|
| [85] |
|
| [86] |
|
| [87] |
|
| [88] |
|
| [89] |
|
| [90] |
|
| [91] |
|
| [92] |
|
| [93] |
|
| [94] |
|
| [95] |
|
| [96] |
|
The Author(s), under exclusive licence to the Huazhong University of Science and Technology
/
| 〈 |
|
〉 |